-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WgZhuN0GWP4pVuIJXniKw5bQkE3OXdD6Eh4njafYMCxEIq/Xa4sG0Uy31JVZyjNr obXp5fZoHTtW0CU7MGw5RA== 0001104659-07-074981.txt : 20071015 0001104659-07-074981.hdr.sgml : 20071015 20071015175958 ACCESSION NUMBER: 0001104659-07-074981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071015 FILED AS OF DATE: 20071015 DATE AS OF CHANGE: 20071015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRENNER LOUIS MD CENTRAL INDEX KEY: 0001389500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 071172808 BUSINESS ADDRESS: BUSINESS PHONE: 617-498-3300 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS, INC STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 a4.xml 4 X0202 4 2007-10-15 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001389500 BRENNER LOUIS MD C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 Senior Vice President Common Stock 2007-10-15 4 M 0 1500 35.29 A 1500 D Common Stock 2007-10-15 4 S 0 1500 68.77 D 0 D Employee Stock Options (Right to Buy) 35.29 2007-10-15 4 M 0 1500 0 D 2016-09-07 Common Stock 1500 41500 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $68.59 to $68.87. This option vests in four equal annual installments. The first installment vested on September 7, 2007 and the remaining installments vest on September 7, 2008, September 7, 2009 and September 7, 2010. /s/ Joseph L. Farmer, attorney-in-fact 2007-10-15 -----END PRIVACY-ENHANCED MESSAGE-----